-
1
-
-
0035807597
-
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
-
de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
-
(2001)
N Engl J Med
, vol.345
, pp. 1014-1021
-
-
de Lemos, J.A.1
Morrow, D.A.2
Bentley, J.H.3
-
2
-
-
0344608881
-
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST elevation MI: BNP and prognosis in TACTICS-TIMI 18
-
Morrow D.A., de Lemos J.A., Sabatine M.S., et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST elevation MI: BNP and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 41 (2003) 1264-1272
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 1264-1272
-
-
Morrow, D.A.1
de Lemos, J.A.2
Sabatine, M.S.3
-
3
-
-
0042809588
-
N-terminal pro brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary disease-a GUSTO IV substudy
-
James S.K., Wallentin L., Armstrong P.W., et al. N-terminal pro brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary disease-a GUSTO IV substudy. Circulation 108 (2003) 275-281
-
(2003)
Circulation
, vol.108
, pp. 275-281
-
-
James, S.K.1
Wallentin, L.2
Armstrong, P.W.3
-
4
-
-
0032546646
-
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
-
Richards A.M., Nicholls M.G., Yandle T.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97 (1998) 1921-1929
-
(1998)
Circulation
, vol.97
, pp. 1921-1929
-
-
Richards, A.M.1
Nicholls, M.G.2
Yandle, T.G.3
-
5
-
-
0029948712
-
Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N- terminal proatrial natriuretic peptide
-
Omland T., Aakvaag A., Bonarjee V.V., et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N- terminal proatrial natriuretic peptide. Circulation 93 (1996) 1963-1969
-
(1996)
Circulation
, vol.93
, pp. 1963-1969
-
-
Omland, T.1
Aakvaag, A.2
Bonarjee, V.V.3
-
6
-
-
33947314211
-
Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes
-
de Lemos J.A., and Morrow D.A. Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes. Am Heart J 153 (2007) 450-453
-
(2007)
Am Heart J
, vol.153
, pp. 450-453
-
-
de Lemos, J.A.1
Morrow, D.A.2
-
7
-
-
34247271336
-
National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes
-
Morrow D.A., Cannon C.P., Jesse R.L., et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 115 (2007) e356-e375
-
(2007)
Circulation
, vol.115
-
-
Morrow, D.A.1
Cannon, C.P.2
Jesse, R.L.3
-
8
-
-
33744455453
-
Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions
-
Chaitman B.R. Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation 113 (2006) 2462-2472
-
(2006)
Circulation
, vol.113
, pp. 2462-2472
-
-
Chaitman, B.R.1
-
9
-
-
0344608880
-
Intracellular Na+ regulation in cardiac myocytes
-
Bers D.M., Barry W.H., and Despa S. Intracellular Na+ regulation in cardiac myocytes. Cardiovasc Res 57 (2003) 897-912
-
(2003)
Cardiovasc Res
, vol.57
, pp. 897-912
-
-
Bers, D.M.1
Barry, W.H.2
Despa, S.3
-
10
-
-
0036801431
-
Defective cardiac ion channels: from mutations to clinical syndromes
-
Clancy C.E., and Kass R.S. Defective cardiac ion channels: from mutations to clinical syndromes. J Clin Invest 110 (2002) 1075-1077
-
(2002)
J Clin Invest
, vol.110
, pp. 1075-1077
-
-
Clancy, C.E.1
Kass, R.S.2
-
11
-
-
0030032681
-
Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts
-
McCormack J.G., Barr R.L., Wolff A.A., and Lopaschuk G.D. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. Circulation 93 (1996) 135-142
-
(1996)
Circulation
, vol.93
, pp. 135-142
-
-
McCormack, J.G.1
Barr, R.L.2
Wolff, A.A.3
Lopaschuk, G.D.4
-
12
-
-
34247526904
-
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial
-
Morrow D.A., Scirica B.M., Karwatowska-Prokopczuk E., et al. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. JAMA 297 (2007) 1775-1783
-
(2007)
JAMA
, vol.297
, pp. 1775-1783
-
-
Morrow, D.A.1
Scirica, B.M.2
Karwatowska-Prokopczuk, E.3
-
13
-
-
33746266565
-
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial
-
Morrow D.A., Scirica B.M., Karwatowska-Prokopczuk E., Skene A., McCabe C.H., and Braunwald E. Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial. Am Heart J 152 (2006) 400-406
-
(2006)
Am Heart J
, vol.152
, pp. 400-406
-
-
Morrow, D.A.1
Scirica, B.M.2
Karwatowska-Prokopczuk, E.3
Skene, A.4
McCabe, C.H.5
Braunwald, E.6
-
14
-
-
11144358465
-
Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study
-
Wu A.H., Packer M., Smith A., et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 50 (2004) 867-873
-
(2004)
Clin Chem
, vol.50
, pp. 867-873
-
-
Wu, A.H.1
Packer, M.2
Smith, A.3
-
15
-
-
28944439267
-
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease
-
Morrow D.A., de Lemos J.A., Blazing M.A., et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. JAMA 294 (2005) 2866-2871
-
(2005)
JAMA
, vol.294
, pp. 2866-2871
-
-
Morrow, D.A.1
de Lemos, J.A.2
Blazing, M.A.3
-
16
-
-
35448971466
-
Universal definition of myocardial infarction
-
Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
-
Thygesen K., Alpert J.S., White H.D., et al., Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 28 (2007) 2525-2538
-
(2007)
Eur Heart J
, vol.28
, pp. 2525-2538
-
-
Thygesen, K.1
Alpert, J.S.2
White, H.D.3
-
17
-
-
35148850168
-
Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non st-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial
-
Scirica B.M., Morrow D.A., Hod H., et al. Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non st-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 116 (2007) 1647-1652
-
(2007)
Circulation
, vol.116
, pp. 1647-1652
-
-
Scirica, B.M.1
Morrow, D.A.2
Hod, H.3
-
18
-
-
0029116749
-
Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction
-
Hama N., Itoh H., Shirakami G., et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (1995) 1558-1564
-
(1995)
Circulation
, vol.92
, pp. 1558-1564
-
-
Hama, N.1
Itoh, H.2
Shirakami, G.3
-
19
-
-
0029055445
-
Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris
-
Marumoto K., Hamada M., and Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Colch) 88 (1995) 551-556
-
(1995)
Clin Sci (Colch)
, vol.88
, pp. 551-556
-
-
Marumoto, K.1
Hamada, M.2
Hiwada, K.3
-
20
-
-
8144225341
-
Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia
-
Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 44 (2004) 1988-1995
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 1988-1995
-
-
Sabatine, M.S.1
Morrow, D.A.2
de Lemos, J.A.3
-
21
-
-
8144219524
-
Detection of exercise-induced ischemia by changes in B-type natriuretic peptides
-
Foote R.S., Pearlman J.D., Siegel A.H., and Yeo K.T. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 44 (2004) 1980-1987
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 1980-1987
-
-
Foote, R.S.1
Pearlman, J.D.2
Siegel, A.H.3
Yeo, K.T.4
-
22
-
-
0033806421
-
Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty
-
Tateishi J., Masutani M., Ohyanagi M., and Iwasaki T. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 23 (2000) 776-780
-
(2000)
Clin Cardiol
, vol.23
, pp. 776-780
-
-
Tateishi, J.1
Masutani, M.2
Ohyanagi, M.3
Iwasaki, T.4
-
23
-
-
33846442057
-
Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial)
-
Bonaca M.P., Wiviott S.D., Sabatine M.S., et al. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial). Am J Cardiol 99 (2007) 344-348
-
(2007)
Am J Cardiol
, vol.99
, pp. 344-348
-
-
Bonaca, M.P.1
Wiviott, S.D.2
Sabatine, M.S.3
-
24
-
-
0042198675
-
B-type natriuretic peptide in cardiovascular disease
-
de Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
-
(2003)
Lancet
, vol.362
, pp. 316-322
-
-
de Lemos, J.A.1
McGuire, D.K.2
Drazner, M.H.3
-
25
-
-
4043152160
-
Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction
-
Sadanandan S., Cannon C.P., Chekuri K., et al. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 44 (2004) 564-568
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 564-568
-
-
Sadanandan, S.1
Cannon, C.P.2
Chekuri, K.3
-
26
-
-
13744259846
-
N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease
-
Kragelund C., Gronning B., Kober L., Hildebrandt P., and Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352 (2005) 666-675
-
(2005)
N Engl J Med
, vol.352
, pp. 666-675
-
-
Kragelund, C.1
Gronning, B.2
Kober, L.3
Hildebrandt, P.4
Steffensen, R.5
-
27
-
-
33748420987
-
Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy
-
James S.K., Lindback J., Tilly J., et al. Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy. J Am Coll Cardiol 48 (2006) 1146-1154
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 1146-1154
-
-
James, S.K.1
Lindback, J.2
Tilly, J.3
-
28
-
-
33947314845
-
N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy
-
Windhausen F., Hirsch A., Sanders G.T., et al. N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy. Am Heart J 153 (2007) 485-492
-
(2007)
Am Heart J
, vol.153
, pp. 485-492
-
-
Windhausen, F.1
Hirsch, A.2
Sanders, G.T.3
-
29
-
-
33646923161
-
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study
-
Scirica B.M., Morrow D.A., Cannon C.P., et al. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study. J Am Coll Cardiol 47 (2006) 2326-2331
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 2326-2331
-
-
Scirica, B.M.1
Morrow, D.A.2
Cannon, C.P.3
-
30
-
-
0026771182
-
A persistent sodium current in rat ventricular myocytes
-
Saint D.A., Ju Y.K., and Gage P.W. A persistent sodium current in rat ventricular myocytes. J Physiol 453 (1992) 219-231
-
(1992)
J Physiol
, vol.453
, pp. 219-231
-
-
Saint, D.A.1
Ju, Y.K.2
Gage, P.W.3
-
31
-
-
0028030471
-
Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart
-
Gralinski M.R., Black S.C., Kilgore K.S., Chou A.Y., McCormack J.G., and Lucchesi B.R. Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart. Cardiovasc Res 28 (1994) 1231-1237
-
(1994)
Cardiovasc Res
, vol.28
, pp. 1231-1237
-
-
Gralinski, M.R.1
Black, S.C.2
Kilgore, K.S.3
Chou, A.Y.4
McCormack, J.G.5
Lucchesi, B.R.6
-
32
-
-
0037163064
-
Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure
-
Chandler M.P., Stanley W.C., Morita H., et al. Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure. Circ Res 91 (2002) 278-280
-
(2002)
Circ Res
, vol.91
, pp. 278-280
-
-
Chandler, M.P.1
Stanley, W.C.2
Morita, H.3
-
33
-
-
0036936426
-
Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure
-
Sabbah H.N., Chandler M.P., Mishima T., et al. Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure. J Card Fail 8 (2002) 416-422
-
(2002)
J Card Fail
, vol.8
, pp. 416-422
-
-
Sabbah, H.N.1
Chandler, M.P.2
Mishima, T.3
-
34
-
-
0036154499
-
Partial fatty acid oxidation inhibitors: a potentially new class of drugs for heart failure
-
Sabbah H.H., and Stanley W.C. Partial fatty acid oxidation inhibitors: a potentially new class of drugs for heart failure. Eur J Heart Fail 4 (2002) 3-6
-
(2002)
Eur J Heart Fail
, vol.4
, pp. 3-6
-
-
Sabbah, H.H.1
Stanley, W.C.2
|